Reck M - Search Results

1

A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).

Mok T, Gorbunova V, Juhasz E, Szima B, Burdaeva O, Orlov S, Yu CJ, Archer V, Hilton M, Delmar P, Pallaud C, Reck M. Mok T, et al. Among authors: reck m. J Thorac Oncol. 2014 Jun;9(6):848-55. doi: 10.1097/JTO.0000000000000160. J Thorac Oncol. 2014. PMID: 24807156 Free article. Clinical Trial.

2

Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.

Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. J Clin Oncol. 1992 May;10(5):818-23. doi: 10.1200/JCO.1992.10.5.818. J Clin Oncol. 1992. PMID: 1314891 Clinical Trial.

3

Carboplatin/etoposide/vincristine therapy in small cell lung cancer.

Gatzemeier U, von Pawel J, Laumen R, Hossfeld DK, Neuhauss R, Reck M, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Oncology. 1992;49 Suppl 1:25-33. doi: 10.1159/000227107. Oncology. 1992. PMID: 1323809 Clinical Trial.

4

Phase II and III studies with carboplatin in small cell lung cancer.

Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Semin Oncol. 1992 Feb;19(1 Suppl 2):28-36. Semin Oncol. 1992. PMID: 1329220 Clinical Trial.

5

Carboplatin in small cell lung cancer.

Gatzemeier U, Hossfeld DK, Neuhauss R, Reck M, Achterrath W, Lenaz L. Gatzemeier U, et al. Among authors: reck m. Semin Oncol. 1991 Feb;18(1 Suppl 2):8-16. Semin Oncol. 1991. PMID: 1846981 Clinical Trial.

6

[Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide].

Gatzemeier U, Achterrath W, Heckmayr M, Hossfeld DK, Neuhauss R, Reck M, Zschaber R. Gatzemeier U, et al. Among authors: reck m. Pneumologie. 1990 Feb;44 Suppl 1:584-5. Pneumologie. 1990. PMID: 2164203 German.

7

Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide--a phase II study.

Reck M, Jagos U, Grunwald F, Kaukel E, Koschel G, von Pawel J, Hessler S, Gatzemeier U. Reck M, et al. Lung Cancer. 2003 Jan;39(1):63-9. doi: 10.1016/s0169-5002(02)00383-5. Lung Cancer. 2003. PMID: 12499096 Clinical Trial.

8

Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.

Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U. Reck M, et al. J Natl Cancer Inst. 2003 Aug 6;95(15):1118-27. doi: 10.1093/jnci/djg017. J Natl Cancer Inst. 2003. PMID: 12902441 Clinical Trial.

9

Gefitinib ("Iressa"): a new therapy for advanced non-small-cell lung cancer.

Reck M, Gatzemeier U. Reck M, et al. Respir Med. 2005 Mar;99(3):298-307. doi: 10.1016/j.rmed.2004.08.009. Respir Med. 2005. PMID: 15733505 Free article. Review.

10

Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.

Reck M, Groth G, Buchholz E, Goetz E, Gatzemeier U, Manegold C. Reck M, et al. Lung Cancer. 2005 Jun;48(3):409-13. doi: 10.1016/j.lungcan.2004.11.013. Epub 2005 Jan 23. Lung Cancer. 2005. PMID: 15893010 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

520 results

Search Page